NUTEX HEALTH REPORTS RESTATED FIRST QUARTER 2025 FINANCIAL RESULTS

Total revenue of $211.8 million for Q1 2025 versus $67.5 million for Q1 2024, an increase of 214.0% Net income attributable to Nutex Health Inc. of $21.2 million for Q1 2025 versus net loss of $0.4 million for Q1 2024, an increase of $21.6 million. Diluted income per share of $3.33 for Q1 2025 versus…

Read More

NUTEX HEALTH REPORTS RESTATED 2024 FINANCIAL RESULTS

FULL YEAR 2024 HIGHLIGHTS: Total revenue of $479.9 million for the year 2024 versus $247.6 million for the year 2023, an increase of 93.8% Net income attributable to Nutex Health Inc. of $52.1 million for 2024 versus net loss of $45.8 million for 2023 Diluted income per share of $9.69 for 2024 versus a loss…

Read More